Genetics of venous thrombosis - PubMed (original) (raw)
Review
Genetics of venous thrombosis
F R Rosendaal et al. J Thromb Haemost. 2009 Jul.
Free article
Abstract
Venous thrombosis (deep vein thrombosis, pulmonary embolism) is a common and serious disorder, with genetic and acquired risk factors. The genetic risk factors can be subdivided in to those that are strong, moderate and weak. Strong risk factors are deficiencies of antithrombin, protein C and protein S. Moderately strong are factor V Leiden, prothrombin 20210A, non-O blood group and fibrinogen 10034T. There are many weak genetic risk factors, including fibrinogen, factor XIII and factor XI variants. Even for moderately strong risk factors (relative risks 2-5), the majority of carriers will never develop thrombosis.
Similar articles
- AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J. Miñano A, et al. Haematologica. 2008 May;93(5):729-34. doi: 10.3324/haematol.12271. Epub 2008 Apr 2. Haematologica. 2008. PMID: 18387978 - [Genetic risk factors of venous thromboembolism].
Oner F, Kaya A, Doğan R, Numanoğlu N. Oner F, et al. Tuberk Toraks. 2003;51(1):60-9. Tuberk Toraks. 2003. PMID: 15100907 Review. Turkish. - Genetic risk factors of venous thrombosis.
Franco RF, Reitsma PH. Franco RF, et al. Hum Genet. 2001 Oct;109(4):369-84. doi: 10.1007/s004390100593. Hum Genet. 2001. PMID: 11702218 Review. - Predictive genetic variants for venous thrombosis: what's new?
Bezemer ID, Rosendaal FR. Bezemer ID, et al. Semin Hematol. 2007 Apr;44(2):85-92. doi: 10.1053/j.seminhematol.2007.01.007. Semin Hematol. 2007. PMID: 17433900 Review. - Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria.
Renner W, Köppel H, Hoffmann C, Schallmoser K, Stanger O, Toplak H, Wascher TC, Pilger E. Renner W, et al. Thromb Res. 2000 Jul 1;99(1):35-9. doi: 10.1016/s0049-3848(00)00219-x. Thromb Res. 2000. PMID: 10904101
Cited by
- Autoimmune diseases and venous thromboembolism: a review of the literature.
Zöller B, Li X, Sundquist J, Sundquist K. Zöller B, et al. Am J Cardiovasc Dis. 2012;2(3):171-83. Epub 2012 Jul 25. Am J Cardiovasc Dis. 2012. PMID: 22937487 Free PMC article. - Classic Thrombophilias and Thrombotic Risk Among Middle-Aged and Older Adults: A Population-Based Cohort Study.
Manderstedt E, Lind-Halldén C, Halldén C, Elf J, Svensson PJ, Dahlbäck B, Engström G, Melander O, Baras A, Lotta LA, Zöller B; Regeneron Genetics Center 4 [Link]. Manderstedt E, et al. J Am Heart Assoc. 2022 Feb 15;11(4):e023018. doi: 10.1161/JAHA.121.023018. Epub 2022 Feb 3. J Am Heart Assoc. 2022. PMID: 35112923 Free PMC article. - Large-scale genetic correlation scanning and causal association between deep vein thrombosis and human blood metabolites.
Luo P, Xu J, Cheng S, Xu K, Jing W, Zhang F, Xu P. Luo P, et al. Sci Rep. 2022 May 12;12(1):7888. doi: 10.1038/s41598-022-12021-x. Sci Rep. 2022. PMID: 35551264 Free PMC article. - Large-scale screening for factor V Leiden (G1691A), prothrombin (G20210A), and MTHFR (C677T) mutations in Greek population.
Raptopoulou A, Michou V, Mourtzi N, Papageorgiou EG, Voyiatzaki C, Tsilivakos V, Beloukas A, Bei TA. Raptopoulou A, et al. Health Sci Rep. 2022 Jul 15;5(4):e457. doi: 10.1002/hsr2.457. eCollection 2022 Jul. Health Sci Rep. 2022. PMID: 35844826 Free PMC article. - The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk.
Khialani D, le Cessie S, Lijfering WM, Cannegieter SC, Rosendaal FR, van Hylckama Vlieg A. Khialani D, et al. Br J Haematol. 2020 Oct;191(1):90-97. doi: 10.1111/bjh.16666. Epub 2020 Apr 27. Br J Haematol. 2020. PMID: 32342502 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical